1-isobutyl-N-(6-(1-methyl-1H-pyrazol-4-yl)isoquinolin-3-yl)piperidine-4-carboxamide

ID: ALA5289681

Max Phase: Preclinical

Molecular Formula: C23H29N5O

Molecular Weight: 391.52

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)CN1CCC(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)CC1

Standard InChI:  InChI=1S/C23H29N5O/c1-16(2)14-28-8-6-17(7-9-28)23(29)26-22-11-20-10-18(4-5-19(20)12-24-22)21-13-25-27(3)15-21/h4-5,10-13,15-17H,6-9,14H2,1-3H3,(H,24,26,29)

Standard InChI Key:  OGPJOAYIAOEJAM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -1.4300   -0.2044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7154    0.2078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0036   -0.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0036   -1.0291    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7136   -1.4409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4300   -1.0328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1456   -1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8634   -1.0312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8652   -0.2069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1507    0.2113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5798    0.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3333   -0.1298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8852    0.4831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4728    1.1974    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6660    1.0259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7099    0.4831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7106    0.2083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4247   -0.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1389    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4247   -1.0286    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1389    1.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8531    1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5673    1.0329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5673    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8531   -0.2039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2815    1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9956    1.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7099    1.4453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9956    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  1 10  1  0
 11  9  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 13 16  1  0
  3 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 21 19  1  0
 22 21  1  0
 23 22  1  0
 24 23  1  0
 25 24  1  0
 19 25  1  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5289681

    ---

Associated Targets(Human)

CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1E Tclin Casein kinase I epsilon (1412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK1 Tchem Dual specificty protein kinase CLK1 (2189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK2 Tchem Dual specificity protein kinase CLK2 (3942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK3 Tchem Dual specificity protein kinase CLK3 (2711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CLK4 Tchem Dual specificity protein kinase CLK4 (4053 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK1A Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 1A (6484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK1B Tchem Dual specificity tyrosine-phosphorylation-regulated kinase 1B (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK2 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 2 (2095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK3 Tchem Dual-specificity tyrosine-phosphorylation regulated kinase 3 (1018 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DYRK4 Tchem Dual specificity tyrosine-phosphorylation-regulated kinase 4 (692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.52Molecular Weight (Monoisotopic): 391.2372AlogP: 3.94#Rotatable Bonds: 5
Polar Surface Area: 63.05Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.05CX Basic pKa: 9.71CX LogP: 3.38CX LogD: 1.10
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.72Np Likeness Score: -1.69

References

1. Lindberg MF, Deau E, Arfwedson J, George N, George P, Alfonso P, Corrionero A, Meijer L..  (2023)  Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases.,  66  (6): [PMID:36876904] [10.1021/acs.jmedchem.2c02068]

Source